IRIS
BALBI, MATILDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.995
AS - Asia 763
NA - Nord America 604
SA - Sud America 59
AF - Africa 15
OC - Oceania 1
Totale 4.437
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.867
US - Stati Uniti d'America 566
SG - Singapore 301
CN - Cina 202
VN - Vietnam 133
BD - Bangladesh 40
HK - Hong Kong 40
BR - Brasile 34
GB - Regno Unito 23
CA - Canada 22
FR - Francia 22
AR - Argentina 15
DE - Germania 14
FI - Finlandia 14
JP - Giappone 9
PL - Polonia 9
IN - India 8
NL - Olanda 8
ES - Italia 5
IQ - Iraq 5
MX - Messico 5
ZA - Sudafrica 5
JM - Giamaica 4
PH - Filippine 4
SI - Slovenia 4
UA - Ucraina 4
CH - Svizzera 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MD - Moldavia 2
PT - Portogallo 2
RU - Federazione Russa 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TR - Turchia 1
YT - Mayotte 1
Totale 4.437
Salva come PNG Salva come JPEG
Città #
Genoa 1.635
Genova 532
Vado Ligure 364
Rapallo 196
San Jose 174
Singapore 163
Ashburn 70
Ho Chi Minh City 43
Beijing 41
Hong Kong 40
Council Bluffs 31
Hanoi 29
New York 25
Lauterbourg 19
Rome 18
Los Angeles 16
Helsinki 13
Bordighera 12
Montreal 11
Santa Clara 11
Da Nang 10
St Louis 10
Haiphong 9
Orem 9
Boardman 8
Frankfurt am Main 8
Milan 8
Staten Island 8
Chicago 7
Miami 7
Naples 7
Boston 6
Piscataway 6
São Paulo 6
Turin 6
Baghdad 5
Tokyo 5
Toronto 5
Amsterdam 4
Bari 4
Basingstoke 4
Buffalo 4
Krakow 4
Kyiv 4
Ljubljana 4
London 4
Madrid 4
Mexico City 4
Tianjin 4
Atlanta 3
Birmingham 3
Bến Tre 3
Castellana Grotte 3
Cisano Bergamasco 3
Dallas 3
Denver 3
Hải Dương 3
Kingston 3
Leipzig 3
Phủ Lý 3
Pisa 3
Shanghai 3
Sherwood Park 3
Warsaw 3
Zurich 3
Ahmedabad 2
Athens 2
Avezzano 2
Bitonto 2
Bologna 2
Braga 2
Bratislava 2
Bridgetown 2
Buenos Aires 2
Can Tho 2
City of London 2
Columbus 2
Curitiba 2
Dhaka 2
Dublin 2
Falconara Marittima 2
Florence 2
Houston 2
Johannesburg 2
Murfreesboro 2
Nairobi 2
Newark 2
North Bergen 2
Phoenix 2
Phủ Từ Sơn 2
Poplar 2
Salt Lake City 2
San Salvador 2
Scranton 2
Tampa 2
Tegucigalpa 2
Tel Aviv 2
Thái Bình 2
Wroclaw 2
Zola Predosa 2
Totale 3.735
Salva come PNG Salva come JPEG
Nome #
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of Glutamate and GABA in the mouse cortex and hippocampus 235
Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. 212
Group I metabotropic glutamatergic receptors regulating glutamate release and microglia phenotype in a murine model of amyotrophic lateral sclerosis 187
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 183
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 151
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 137
GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE 135
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 134
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 129
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 122
Glucagon Like Peptide-1 increases glutamate release in the mouse cerebral cortex and hippocampus by activacting presynaptic GLP-1R 114
null 114
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 113
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 111
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 109
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 107
Phenotype changes of microglia in SOD1G93A mice after mGluR5 genetic down regulation 107
cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION 106
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 101
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis 98
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 88
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 87
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 85
MSC-derived extracellular vesicles for the treatment of ALS 85
Multiple approaches reveal altered lipid metabolism, neurotransmitter release and nervous conduction in a zebrafish model of Alexander Disease 82
PRESYNAPTIC GLP-1 RECEPTORS ENHANCE GLUTAMATE AND GABA RELEASE FROM PURIFIED MOUSE CORTICAL AND HIPPOCAMPAL SYNAPTOSOMES 77
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 76
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 75
Efficacy and Safety of Visible and Near-Infrared Photobiomodulation Therapy on Astenospermic Human Sperm: Wavelength-Dependent Regulation of Nitric Oxide Levels and Mitochondrial Energetics 72
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 72
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 71
Sex-specific motor and behavioural parameters for early stratification of ALS progression in SOD1(G93A) mice. 70
Combined motor and behavioural tracking approach to stratify ALS progression in SOD1(G93A) mice. 70
Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia 68
Partial deletion of mGluR5 affects microglia inflammatory phenotype, bioenergetic characteristics, and red-ox state during ALS progression in SOD1G93A mice 67
The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models 67
Synapto-gliosomal characterization in a zebrafish model of Alexander disease 65
Changes of the microglia phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis after mGluR5 genetic down-regulation 65
Partial deletion of mGluR5 affects M1 and M2 phenotypes in microglia acutely isolated from SOD1(G93A) mice during disease progression 65
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 60
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 58
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 58
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 56
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 55
miR-29a-3p and TGF-β Axis in Fanconi anemia: mechanisms driving metabolic dysfunction and genome stability 45
The partial deletion of mGluR5 affects the pro- and anti-inflammatory and bioenergetic characteristics of microglia during ALS progression in SOD1(G93A) mice 44
Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism 43
Fanconi Anemia: Interplay Between DNA Repair Defects, Mitochondrial Dysfunction, and Oxidative Stress 9
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR–DRP1 modulation 7
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 7
The impact of near-infrared photobiomodulation therapy on human oocyte rescue in vitro maturation 4
null 1
null 1
Totale 4.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.323
article - articoli 5.566
book - libri 0
conference - conferenze 8.322
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022182 1 8 13 11 7 10 23 37 17 16 17 22
2022/2023245 24 20 7 19 21 28 2 22 50 6 44 2
2023/2024301 6 23 23 32 29 48 19 18 4 20 28 51
2024/20251.045 56 47 24 80 105 93 107 183 33 68 109 140
2025/20262.381 246 79 171 184 314 114 310 198 247 255 204 59
Totale 4.560